Yew Bio-Pharm Group, Inc. announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced total revenue was USD 2.029 million compared to USD 11.514 million a year ago. Operating income was USD 157,388 compared to USD 545,274 a year ago. Net income was USD 151,412 compared to USD 377,042 a year ago. Basic eps - continuing operations was USD 0 compared to USD 0.01 a year ago.